cupure logo
cancerriskdoctorsstudywarningpeoplecommonalertdiseasehealthy

Experimental drug helps patients lose nearly a quarter of body weight in early trials

Experimental drug helps patients lose nearly a quarter of body weight in early trials
Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly one-quarter of their body weight in early trials.

Comments

Health news